Navigation Links
Cardium Provides Update on Exchange Listing and Related Business Matters
Date:8/29/2011

://www.cardiumthx.com/">www.cardiumthx.com.

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations.  For example, there can be no assurance that the company can successfully expand its MedPodium business and launch its other product candidates, that it can achieve and maintain compliance with the requirements of its listing exchange or that its shares can continue to be listed on national exchange, that results observed in one study or using one type of product or procedure will be replicated in subsequent studies or in studies using newly-developed products or procedures, that planned product development efforts and clinical studies can be performed in an efficient and effective manner, that regulatory approvals can be obtained in a timely manner or at all, that partnering, distribution or other commercialization efforts can be achieved, that product modifications or launches will be successful or that the resulting products will be favorably received in the marketplace, that our products or proposed products will prove to be sufficiently safe and effective, that our products or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive, that results or trends observed in one clinical study will be reproduced in subsequent studies, that third parties on whom we depend will behave as anticipated, or that necessary regulatory approvals will be obtained.  Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
4. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
7. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
8. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
9. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
10. Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development
11. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014 North America Gynecological Devices ... GlobalData,s new report, "North America Gynecological ... data on the North America Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ...
(Date:9/17/2014)... NEW YORK , Sept. 17, 2014 ... significant growth during the last decade due ... environment, natural calamities and technological advancements. This ... strategies within various segments of the ambulance ... as transportation equipment, blood and hemorrhage control ...
(Date:9/17/2014)... 17, 2014  Decision Resources Group finds ... eligible for biologic therapy, only a proportion ... gastroenterologists cite patients, discomfort with biological therapy ... rates, followed by cost-related issues and payer ... biologics, Janssen Biotech,s Remicade and AbbVie,s Humira ...
Breaking Medicine Technology:North America Gynecological Devices Market Outlook to 2020 2North America Gynecological Devices Market Outlook to 2020 3Ambulance and Emergency Equipment: Global Markets 2Ambulance and Emergency Equipment: Global Markets 3Ambulance and Emergency Equipment: Global Markets 4The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3
... 2012  Sensitech Inc., the global leader in cold ... Transport Association (IATA) has deemed Sensitech,s full range ... in compliance with the 53rd edition of the ... published by the United Nations.   The size and ...
... FRANCISCO, April 26, 2012 Onyx Pharmaceuticals, Inc. (Nasdaq: ... Food and Drug Administration,s (FDA) Oncologic Drugs Advisory Committee ... for carfilzomib for the treatment of patients with relapsed ... two prior therapies. ODAC will review carfilzomib at its ...
Cached Medicine Technology:Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA 2Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma 2Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma 3
(Date:9/18/2014)... N-Zyme Scientifics LLC achieved a major developmental milestone ... mere 8 months after company startup. Its novel product ... enzyme used in the “Biologics” industry for discovery and ... pathology on Mass Spec devices. PRIME™ is being sold ... market (PNGase F PRIMETM). N-Zyme is currently evaluating ...
(Date:9/17/2014)... 18, 2014 The global ablation technologies ... 9.6% from 2014 to 2019. Although mature markets (such ... larger shares in the ablation technologies market in 2014, ... highest CAGR of 12.8% in the next five years.Factors ... infrastructure, growing number of hospitals and surgical centers, and ...
(Date:9/17/2014)... 18, 2014 iFitDress.com, a renowned wedding dress ... petite evening dresses . All these outfits are now ... discounted shipping costs. , “iFitDress.com is a professional company ... We are now busy selling our new collection of petite ... an order above $800 can get free shipping. All these ...
(Date:9/17/2014)... 2014 Mercy College is proud to welcome ... of Social and Behavioral Sciences. As dean, she ... the academic mission of the dynamic undergraduate and graduate programs ... honored to join Mercy College. During my first three ... campuses dedicated to the educational mission of the College. ...
(Date:9/17/2014)... Lake City, UT (PRWEB) September 17, 2014 ... Miss America 2015 Kira Kazantsev and ushered in ... need charitable support. As Miss America Organization’s official ... is welcoming Kazantsev as its newest National Goodwill ... her at member Children’s Miracle Network Hospitals across ...
Breaking Medicine News(10 mins):Health News:N-Zyme Scientifics Announces Successful Product Launch 2Health News:9.6% CAGR for Ablation Technologies Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:9.6% CAGR for Ablation Technologies Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:9.6% CAGR for Ablation Technologies Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4Health News:Elegant Petite Evening Dresses Introduced By Renowned Supplier iFitDress.com 2Health News:Mercy College Welcomes New Dean of the School of Social and Behavioral Sciences 2Health News:Miss America 2015 Kira Kazantsev Takes On Role as Children’s Miracle Network Hospitals National Goodwill Ambassador 2Health News:Miss America 2015 Kira Kazantsev Takes On Role as Children’s Miracle Network Hospitals National Goodwill Ambassador 3
... Sept. 20 Approximately 100,corporate pilots and ... earn,lifesaving certifications provided by the American Heart ... Safety Standdown in Wichita, Kan.,Oct. 22-25. ... event offers safety,training to the business aviation ...
... single dose of Otsukas investigational oral medication tolvaptan, ... in hemodynamics associated with a significant increase in ... (ADHF) who participated in the international trial the ... with HEart failure (ECLIPSE), presented at the late ...
... Inc.,(TSX: LOR; AMEX: LRP), a biopharmaceutical company specializing ... technologies for,the management of cancer, today announced that ... Vincent were elected to the Board of Directors ... 19, 2007. Dr. Burger has been,unanimously elected as ...
... A Florida pharmacy,owner and a Kentucky physician pleaded ... pharmacy business that generated more than,$126 million in ... Assistant Attorney General Alice S. Fisher of the ... the Southern District of,California announced today. Claude ...
... ... Zoo, Chicago, FAIRFAX, Va., Sept. 19 ... heavy vaginal,bleeding caused by uterine fibroids, noncancerous tumors that develop in,the muscular ... of Chicago, IL, and is a 46-year-old menopausal western lowland,gorilla. Doctors have ...
... Event to Take Place Friday February 8th, 2008, ... Inc. of Rancho Mirage, will host its first,annual Gala, ... A. Lopez, Director of Internal Medicine Specialists-Rancho,Mirage. The elegant ... Resort in Rancho Mirage and will begin at 6:00 ...
Cached Medicine News:Health News:MedAire to Provide Medical Training for Bombardier Safety Standdown 2Health News:MedAire to Provide Medical Training for Bombardier Safety Standdown 3Health News:ECLIPSE data on effects of Otsuka's investigational novel treatment, Tolvaptan 2Health News:Lorus Therapeutics announces election of three new Directors and appoints a new Chairman 2Health News:Lorus Therapeutics announces election of three new Directors and appoints a new Chairman 3Health News:Lorus Therapeutics announces election of three new Directors and appoints a new Chairman 4Health News:Doctor and Pharmacy Owner Plead Guilty in Internet Pharmacy Conspiracy 2Health News:Doctor and Pharmacy Owner Plead Guilty in Internet Pharmacy Conspiracy 3Health News:Gorilla Receives State-Of-The-Art Treatment for Uterine Fibroids from Interventional Radiologists 2Health News:Gorilla Receives State-Of-The-Art Treatment for Uterine Fibroids from Interventional Radiologists 3Health News:IMA South American Extravaganza Dinner to Honor Coachella Valley Doctor 2
... high-end microplate reader with outstanding sensitivity and ... Fluorescence Intensity - FRET , Fluorescence Polarization ... , Luminescence , , , ... reader with fastest read times. The ultimate ...
GENios Pro, TECANs advanced, multi-functional injector reader offers simultaneous reagent dispensing and detection for monitoring of fast kinetic reactions...
... Throughput Screening (UHTS), Analyst GT delivers ... for smooth transfer of assays into ... all the detection modalities of Analyst ... polarization, time-resolved fluorescence, luminescence, absorbance, as ...
... a fully automated microplate based multi-detection ... principles:, , Fluorescence Polarization , ... , High-Performance Luminescence (flash and glow) ... is designed for the widest possible ...
Medicine Products: